PL2150253T3 - Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego - Google Patents

Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Info

Publication number
PL2150253T3
PL2150253T3 PL08787962T PL08787962T PL2150253T3 PL 2150253 T3 PL2150253 T3 PL 2150253T3 PL 08787962 T PL08787962 T PL 08787962T PL 08787962 T PL08787962 T PL 08787962T PL 2150253 T3 PL2150253 T3 PL 2150253T3
Authority
PL
Poland
Prior art keywords
oxydopyridin
cyclopropylmethoxy
carboxamide
dichloro
pyridine
Prior art date
Application number
PL08787962T
Other languages
English (en)
Inventor
Philippe Delay-Goyet
Badia Ferzaz
Jocelyne Lolivier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PL2150253T3 publication Critical patent/PL2150253T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL08787962T 2007-04-19 2008-04-16 Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego PL2150253T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0702851A FR2915098B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
PCT/FR2008/000533 WO2008145840A2 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
EP08787962A EP2150253B1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Publications (1)

Publication Number Publication Date
PL2150253T3 true PL2150253T3 (pl) 2011-08-31

Family

ID=38779706

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08787962T PL2150253T3 (pl) 2007-04-19 2008-04-16 Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Country Status (33)

Country Link
US (1) US8592443B2 (pl)
EP (1) EP2150253B1 (pl)
JP (1) JP5386477B2 (pl)
KR (1) KR101470043B1 (pl)
CN (1) CN101674829B (pl)
AR (1) AR066106A1 (pl)
AT (1) ATE503481T1 (pl)
AU (1) AU2008257321B2 (pl)
BR (1) BRPI0810446A2 (pl)
CA (1) CA2684172C (pl)
CL (1) CL2008001134A1 (pl)
CY (1) CY1111779T1 (pl)
DE (1) DE602008005873D1 (pl)
DK (1) DK2150253T3 (pl)
EA (1) EA015355B1 (pl)
ES (1) ES2363056T3 (pl)
FR (1) FR2915098B1 (pl)
HR (1) HRP20110459T1 (pl)
IL (1) IL201451A (pl)
JO (1) JO2662B1 (pl)
MA (1) MA31369B1 (pl)
ME (1) ME00934B (pl)
MX (1) MX2009011285A (pl)
MY (1) MY146657A (pl)
NZ (1) NZ580483A (pl)
PA (1) PA8776601A1 (pl)
PL (1) PL2150253T3 (pl)
PT (1) PT2150253E (pl)
PY (1) PY08013253A (pl)
SI (1) SI2150253T1 (pl)
TW (1) TWI411435B (pl)
UY (1) UY31033A1 (pl)
WO (1) WO2008145840A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915099B1 (fr) 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
KR20150087252A (ko) * 2012-11-28 2015-07-29 사노피 4-(사이클로프로필메톡시)-n-(3,5-디클로로-1-옥시도피리딘-4-일)-5-메톡시피리딘-2-카복스아미드의 결정 형태의 제조 방법 및 이의 결정 형태
RU2635094C2 (ru) * 2012-11-28 2017-11-09 Санофи Способ получения 4-(циклопропилметокси)-n-(3,5-дихлор-1-оксидо-4-пиридил)-5-метоксипиридин-2-карбоксамида
US20220226302A1 (en) 2021-01-20 2022-07-21 Altos Neuroscience, Inc. Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions
WO2025079694A1 (ja) * 2023-10-12 2025-04-17 株式会社 メドレックス 経皮吸収組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
ES2176251T3 (es) 1993-07-28 2002-12-01 Aventis Pharma Ltd Compuestos utilizados como inhibidores de pde iv y del factor de necrosis tumoral(tnf).
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9507297D0 (en) 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
US6196968B1 (en) 1997-06-02 2001-03-06 General Surgical Innovations, Inc. Direct vision subcutaneous tissue retractor and method for use
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
WO2001047915A1 (en) 1999-12-23 2001-07-05 Icos Corporation Cyclic amp-specific phosphodiesterase inhibitors
HUP0600103A2 (en) 2001-03-02 2006-06-28 Bristol Myers Squibb Co Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
WO2004005258A1 (en) 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
WO2004067006A1 (en) 2003-01-27 2004-08-12 Pharmacia Corporation Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2005032493A2 (en) * 2003-10-07 2005-04-14 Renovis, Inc. Amide compounds as ion channel ligands and uses thereof
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
MX2009011285A (es) 2009-11-02
US8592443B2 (en) 2013-11-26
IL201451A (en) 2013-04-30
HK1142000A1 (en) 2010-11-26
CA2684172C (fr) 2015-10-27
WO2008145840A3 (fr) 2009-06-25
MY146657A (en) 2012-09-14
CA2684172A1 (fr) 2008-12-04
KR20090130063A (ko) 2009-12-17
KR101470043B1 (ko) 2014-12-05
PA8776601A1 (es) 2008-11-19
FR2915098B1 (fr) 2009-06-05
PY08013253A (es) 2013-08-01
AU2008257321B2 (en) 2013-08-15
EA200970969A1 (ru) 2010-02-26
DE602008005873D1 (de) 2011-05-12
AR066106A1 (es) 2009-07-22
MA31369B1 (fr) 2010-05-03
CL2008001134A1 (es) 2009-01-16
US20100137370A1 (en) 2010-06-03
NZ580483A (en) 2011-06-30
HRP20110459T1 (hr) 2011-07-31
ATE503481T1 (de) 2011-04-15
JP5386477B2 (ja) 2014-01-15
AU2008257321A1 (en) 2008-12-04
CN101674829B (zh) 2012-01-18
PT2150253E (pt) 2011-06-17
TWI411435B (zh) 2013-10-11
ES2363056T3 (es) 2011-07-19
BRPI0810446A2 (pt) 2014-10-14
SI2150253T1 (sl) 2011-07-29
EP2150253B1 (fr) 2011-03-30
CN101674829A (zh) 2010-03-17
EA015355B1 (ru) 2011-06-30
EP2150253A2 (fr) 2010-02-10
TW200911248A (en) 2009-03-16
IL201451A0 (en) 2010-05-31
CY1111779T1 (el) 2015-10-07
WO2008145840A2 (fr) 2008-12-04
UY31033A1 (es) 2008-11-28
JP2010524905A (ja) 2010-07-22
FR2915098A1 (fr) 2008-10-24
JO2662B1 (en) 2012-06-17
ME00934B (me) 2012-06-20
DK2150253T3 (da) 2011-07-25

Similar Documents

Publication Publication Date Title
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
EP1874259A4 (en) TREATMENT DEVICE FOR KNEES TRACKING
BRPI0808246A2 (pt) "fralda descartável".
IL184710A0 (en) 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
EP2116255A4 (en) MEANS FOR THE TREATMENT OF BACKBREAK INJURIES
ITMI20072397A1 (it) Apparecchiatura medicale per il trattamento extracorporeo
IL206657A0 (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
DK2150253T3 (da) Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader
ZA201005306B (en) 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
PT2146714E (pt) Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxidopiridin- 4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento dos distúrbios motores relacionados com a doença de parkinson
PL2129373T3 (pl) Zastosowanie genisteiny do leczenia zespołu suchego oka
PL2146713T3 (pl) Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksyamidu do leczenia urazów mózgowych
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
GB0721616D0 (en) Treatment of spinal cord injury
TH0801001896A (th) การใช้ 4-ไซโคลโพรพิลเมธอกซิ-n-(3,5-ไดคลอโร-1-ออกซิโด-ไพริดิน-4-อิล)-5-(เมธอกซิ)ไพริดีน-2-คาร์บอกซามีด ในการรักษาการบาดเจ็บไขสันหลัง
FI20075143A0 (fi) Laite potilaan lämmittämiseksi
ES1067907Y (es) Aparato gimnastico de abdominales extensible apto para usar en la cama o cualquier otra superficie.
GB0704664D0 (en) Treatment device 3
GB0704662D0 (en) Treatment device 2
GB0700886D0 (en) Medical treatment
SE0400576D0 (sv) A novel pharmacentical composition for the treatment of spinal cord injury